|
|
.
See Category: Neoplasms
See Header: Squamous cell carcinoma of skin of lower limb, including hip
ICD-10 (CM) Code and Descriptor
|
C44.722 |
Squamous cell carcinoma of skin of right lower limb, including hip
|
C44722 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 51.37%
|
23.89%
|
10.04%
|
4.80%
|
2.94%
|
2.11%
|
1.44%
|
1.11%
|
0.69%
|
0.43%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.722*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
4,710
|
6,127
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,879
|
2,887
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
1,632
|
1,634
|
|
17313
|
MOHS 1 STAGE T/A/L |
1,344
|
1,392
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
784
|
784
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
765
|
766
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
683
|
18,591
|
|
J3010
|
FENTANYL CITRATE INJECTION |
606
|
936
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
576
|
2,165
|
|
11602
|
EXC TR-EXT MAL+MARG 1.1-2 CM |
565
|
569
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
497
|
625
|
|
J2405
|
ONDANSETRON HCL INJECTION |
458
|
1,888
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
432
|
433
|
|
11606
|
EXC TR-EXT MAL+MARG >4 CM |
431
|
437
|
|
13121
|
CMPLX RPR S/A/L 2.6-7.5 CM |
427
|
427
|
|
11603
|
EXC TR-EXT MAL+MARG 2.1-3 CM |
395
|
398
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
395
|
395
|
|
17000
|
DESTRUCT PREMALG LESION |
388
|
388
|
|
77336
|
RADIATION PHYSICS CONSULT |
360
|
360
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
351
|
6,298
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.722 related to the following DRG Codes:
606-607
|
